Document is current
Any future updates will be listed below
-
Authors
Wu, Hsueh-Fu
Saini, Tripti
Art, Jennifer
Delaney, William
Lefcort, Frances
Zeltner, Nadja https://orcid.org/0000-0002-2978-2507
- License Information
-
More Information
Article History
Received: 3 September 2025
Accepted: 16 March 2026
First Online: 9 April 2026
Declarations
:
: F.L. is the CSO of Tikun Therapeutics, owned by the Familial Dysautonomia Foundation. N.Z. is the founder and owner of Neela Cell Therapeutics. Sensory neuron differentiation protocol is patented under US 12,129,483 B2. On behalf of all the authors, the corresponding author states that there are no other conflicts of interest with any other party.
